Related Experiment Video
Updated: Jun 2, 2026
08:29
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
Dementia and Parkinson's disease.
1Department of Neurology, Guy's Hospital, London.
Summary
Dementia in Parkinson's disease involves complex neurological and pathological changes. Neuropsychological deficits arise from disrupted brain region interactions, distinct from global dementia.
Area of Science:
- Neuroscience
- Neurology
- Pathology
Background:
- Parkinson's disease dementia (PDD) presents challenges in correlating clinical symptoms with pathological findings.
- Neuropsychological deficits in PDD are linked to disruptions in basal ganglia and frontal lobe connectivity.
Purpose of the Study:
- To clarify the relationship between clinical observations and pathological hallmarks in Parkinson's disease dementia.
- To investigate the underlying causes of specific neuropsychological deficits in PDD.
Main Methods:
- Analysis of clinical data and pathological examination of brain tissue.
- Neuropsychological testing to assess cognitive function.
Main Results:
- Specific neuropsychological deficits are associated with basal ganglia-frontal lobe interaction disruptions.
- These deficits are independent of the global dementia prevalence in Parkinson's disease, which is notably higher than in the general population.
- Pathological findings include cortical pathology (Alzheimer's disease or Lewy bodies) and degeneration of the basal nucleus of Meynert.
Conclusions:
- Parkinson's disease dementia is characterized by distinct pathological features and specific cognitive impairments.
- Understanding these distinct features is crucial for accurate diagnosis and management of PDD.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...